Potential of Plant-sourced Phenols for Inflammatory Bowel Disease

Author(s): Hai-tao Xiao, Bo Wen, Xiang-chun Shen*, Zhao-xiang Bian*

Journal Name: Current Medicinal Chemistry

Volume 25 , Issue 38 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Inflammatory bowel disease (IBD) is an uncontrolled chronic inflammatory intestinal disorder, which requires medications for long-term therapy. Facing the challenges of severe side effects and drug resistance of conventional medications, to develop the strategies meet the stringent safety and effectiveness in the long-term treatment are urgent in the clinics. In this regard, a growing body of evidence confirms plant-sourced phenols, such as flavonoids, catechins, stilbenes, coumarins, quinones, lignans, phenylethanoids, cannabinoid phenols, tannins, phenolic acids and hydroxyphenols, exert potent protective benefits with fewer undesirable effects in conditions of acute or chronic intestinal inflammation through improvement of colonic oxidative and pro-inflammatory status, preservation of the epithelial barrier function and modulation of gut microbiota. In this review, the great potential of plant-sourced phenols and their action mechanisms for the treatment or prevention of IBD in recent research are summarized, which may help further development of new preventive/adjuvant regimens for IBD.

Keywords: Inflammatory bowel disease, plant-sourced phenols, therapeutic effects, action mechanism, ulcerative colitis, Crohn's disease, colonic tissue edema.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 07 January, 2019
Page: [5191 - 5217]
Pages: 27
DOI: 10.2174/0929867324666171009100900
Price: $65

Article Metrics

PDF: 26